Breast cancer is the most prevalent malignancy among women worldwide. Phototheranostics—an approach that uses light both to ...

The Lung Cancer Research Foundation (LCRF) is pleased to announce the expansion of its Research Advocates. This select group of volunteers are patients, survivors, caregivers, healthcare professionals ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives ...

OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA®, a leading provider ...

Black Diamond Therapeutics's novel EGFR inhibitor shows promise in addressing resistance mutations in NSCLC and glioblastoma.

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...

The World Health Organization estimates a surge in new cancer cases to 23.6 million per year by 2030. This alarming projection underscores the urgent need for effective cancer treatments, positioning ...

EGFR-mutant lung cancer is a rapidly evolving disease landscape ... Intensification strategies, for example, aim to enhance the effectiveness of EGFR-targeted therapies by combining TKIs with other ...

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...

A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or ...